This Month's Profile Group, Antibodies Evolve, features profiles of GamaMabs, Numab, and Zebra Biologics. Plus these Start-Ups Across Health Care: CoolCore Biomedical Technologies, EBS Technologies, and Xeltis.
At the cutting edge of a mature field, new players strive to improve upon existing therapeutic antibodies. Methods for discovering and developing drugs of this kind are evolving along with clinical and commercial expectations and practices.
GamaMabs Pharma SA is one of the latest contenders aiming to boost the biological activity of antibodies by altering...
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Recursion recently announced the completion of a $30m microglia map and named Najat Khan as CEO, replacing co-founder Chris Gibson.
Patient advocacy organizations are transforming gene therapy development by funding research, de-risking programs and driving ultra-rare disease treatments from concept to clinic at unprecedented speed.
